Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 19.04
-0.15 (-0.78%)
Sep 8, 2025, 2:45 PM CST
SHE:300601 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 73.85 | 201.65 | 861.3 | -132.71 | 1,263 | 679.19 | Upgrade |
Depreciation & Amortization | 367.19 | 310.68 | 201.39 | 200.95 | 404.71 | 92.93 | Upgrade |
Other Amortization | 51.06 | 42.78 | 39.33 | 28.1 | 28.35 | 13.56 | Upgrade |
Loss (Gain) From Sale of Assets | 8.88 | 8.42 | 1.35 | -0.13 | -0.03 | 0.29 | Upgrade |
Asset Writedown & Restructuring Costs | 13.49 | 15.57 | 3.32 | 624.09 | 3.41 | 9.63 | Upgrade |
Loss (Gain) From Sale of Investments | -0.67 | -1.85 | -1.89 | -4.12 | -29.71 | -43.82 | Upgrade |
Provision & Write-off of Bad Debts | 21.57 | 29.74 | 12.49 | 39.64 | 10.45 | 20.32 | Upgrade |
Other Operating Activities | 231.39 | 250.25 | 137.25 | 384.44 | 217.36 | 2.54 | Upgrade |
Change in Accounts Receivable | -127.59 | -20.26 | -417.18 | -488.76 | 273.88 | -796.49 | Upgrade |
Change in Inventory | 43.25 | -79.03 | 8.68 | 220.75 | -746.67 | -209.73 | Upgrade |
Change in Accounts Payable | -50.29 | -183.76 | 111.31 | -130.98 | 146.54 | 451.25 | Upgrade |
Change in Other Net Operating Assets | 56.19 | 86.99 | -3.19 | 9.97 | 29.95 | 126.95 | Upgrade |
Operating Cash Flow | 621.33 | 603.25 | 1,033 | 545.7 | 1,652 | 439.85 | Upgrade |
Operating Cash Flow Growth | -17.31% | -41.61% | 89.32% | -66.97% | 275.65% | -13.02% | Upgrade |
Capital Expenditures | -355.74 | -472.18 | -718.45 | -1,310 | -2,540 | -1,227 | Upgrade |
Sale of Property, Plant & Equipment | 16.2 | 16.15 | 0.96 | 0.08 | 0.19 | 1.02 | Upgrade |
Investment in Securities | 34 | -157.4 | 218 | -1,338 | 1,037 | -2,625 | Upgrade |
Other Investing Activities | 41.85 | 56.74 | 60.62 | 42.01 | 63.2 | 13.73 | Upgrade |
Investing Cash Flow | -263.69 | -556.69 | -438.87 | -2,606 | -1,440 | -3,837 | Upgrade |
Long-Term Debt Issued | - | 212.62 | 379.91 | 529.46 | 3,141 | 91.11 | Upgrade |
Long-Term Debt Repaid | - | -743.15 | -299.43 | -1,070 | -26.48 | -256.02 | Upgrade |
Net Debt Issued (Repaid) | -312.63 | -530.53 | 80.48 | -540.98 | 3,115 | -164.91 | Upgrade |
Issuance of Common Stock | - | - | - | 587.29 | 164.74 | 3,519 | Upgrade |
Repurchase of Common Stock | - | - | -100.99 | -20.55 | - | -0.21 | Upgrade |
Common Dividends Paid | -126.16 | -256.62 | -237.23 | -622.15 | -220.42 | -207.32 | Upgrade |
Other Financing Activities | -14.06 | -13.61 | -160.31 | 131.52 | -607.18 | 632.17 | Upgrade |
Financing Cash Flow | -452.85 | -800.76 | -418.05 | -464.88 | 2,452 | 3,779 | Upgrade |
Foreign Exchange Rate Adjustments | -0.23 | -0.06 | 0.04 | -1.66 | -0.98 | -0.04 | Upgrade |
Net Cash Flow | -95.45 | -754.26 | 176.22 | -2,527 | 2,663 | 381.61 | Upgrade |
Free Cash Flow | 265.59 | 131.07 | 314.65 | -764.7 | -888.15 | -786.81 | Upgrade |
Free Cash Flow Growth | 100.12% | -58.34% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 9.35% | 4.94% | 9.05% | -24.22% | -24.32% | -34.80% | Upgrade |
Free Cash Flow Per Share | 0.22 | 0.12 | 0.28 | -0.69 | -0.80 | -0.73 | Upgrade |
Cash Income Tax Paid | 132.72 | 122.5 | 85.74 | 185.63 | 38.68 | 149.75 | Upgrade |
Levered Free Cash Flow | 3.83 | -275.34 | 78.23 | -887.61 | -1,972 | -650.92 | Upgrade |
Unlevered Free Cash Flow | 78.42 | -197.76 | 149.3 | -819.5 | -1,938 | -649.46 | Upgrade |
Change in Working Capital | -145.43 | -253.99 | -221.42 | -594.56 | -245.63 | -334.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.